Search For "bharat biotec"
IVI, Bharat Biotech announce start of global Phase II/III clinical trial o
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], August 25 (ANI): The International Vaccine Institute (IVI) and Bharat Biotech on Wednesday announced the beginning of Phase II/III clinical trial of Chikungunya vaccine candidate (BBV87) in Costa Rica.
Read More
Indian Immunologicals hands over first lot of Covaxin drug substance to Bh
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], August 13 (ANI): In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bha
Read More
75 mn Covaxin doses supplied, more by September, says Bharat Biotech's Suc
Updated : 4 years, 9 months ago IST
New Delhi [India], August 12 (ANI): Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
Read More
Union Minister Mansukh Mandaviya meets WHO Chief Scientist Dr Soumya Swami
Updated : 4 years, 9 months ago IST
New Delhi [India], August 12 (ANI): Union Health Minister Mansukh Mandaviya on Thursday met World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan and held a discussion over the world body's approval of Bharat Biotech's Covaxin.
Read More
Facility augmentation of Bharat Biotech, 3 other PSEs being supported for
Updated : 4 years, 10 months ago IST
New Delhi [India], August 7 (ANI): The Union Ministry of Chemicals and Fertilizers on Friday informed that facility augmentation of Bharat Biotech and three other public sector enterprises (PSEs) are being supported and for augmented production of Covaxin.
Read More
Every batch of Covaxin subjected to over 200 quality control tests: Bharat
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], August 5 (ANI): Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and quality issues, Hyderabad-based manufacturer Bharat Biotech on Thursday said every batch of Covaxin[?] is subjected to more than 200 quality c
Read More
Covaxin receives certificate of Good Manufacturing Practice from Hungarian
Updated : 4 years, 10 months ago IST
New Delhi [India], August 5 (ANI): Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
Read More
Initial hiccups in Bharat Biotech Banglaore plant delayed Covaxin producti
Updated : 4 years, 10 months ago IST
New Delhi [India], August 2 (ANI): India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group (NTAGI) said and added that some hiccups like initial difficulties in the new Bangalore plant of Bhara
Read More
Covaxin is effective against Delta Plus variant of Covid-19, says study
Updated : 4 years, 10 months ago IST
New Delhi [India], August 2 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has shown less reduction in 'neutralizing activity' while comparing with Delta and Delta AY.1 (Delta plus) variants in those who are fully vaccinated with the vaccine according to a study by the Indian Council of
Read More
Vice President visits Bharat Biotech's facility in Hyderabad
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], July 30 (ANI): Vice President M Venkaiah Naidu on Friday visited pharma major Bharat Biotech's COVID-19 vaccine manufacturing facility in Hyderabad.
Read More
COVAXIN trial results on children likely by September: AIIMS chief Dr Rand
Updated : 4 years, 10 months ago IST
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
Read More
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
Updated : 4 years, 10 months ago IST
New Delhi [India], July 23 (ANI): Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil.
Read More